explore -WSS

explore

author：knowledge 2025-10-01 23:39:48 - browse：67185

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： As the dark side of IVF slowly comes into focus, even more transparency is needed

WSS

CDC: Cases of alpha

Biden to sign 'historic' executive order on how US military handles sexual assault cases

Public health communication lessons from Covid

FDA's Pazdur wants cancer trials to range beyond China alone

As the dark side of IVF slowly comes into focus, even more transparency is needed

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

hotspot

explore

hotspot

Supreme Court strikes down use of affirmative action

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

What does generative AI mean for health care? We asked experts

CDC: Cases of alpha

ChatGPT in medicine: STAT answers readers' burning questions

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Peter Hotez and the public health issue of online harassment

Marc Tessier

In age of alternative facts, a scholarly course on calling out crap

Intellia reports positive results for its CRISPR

explore

CDC: Cases of alpha

ASCO: AstraZeneca says CAR

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Change Healthcare can notify patients about the breach, HHS says

hotspot

hotspot

focus

knowledge